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Abstract
Periodontitis is a chronic inflammatory condition characterized by destruction of  non- 
mineralized and mineralized connective tissues. The pathogenesis of periodontitis 
involves a complex interplay between periodontopathogens and the host immunity, 
greatly influenced by genetic and environmental factors. Failure in the inflammation 
resolving mechanism leads to establishment of a chronic inflammatory process, result-
ing in the progressive destruction of bone and soft tissue. The aim of this chapter is to 
summarize the role of innate and specific immune response involved in pathogenesis 
of periodontitis. Cells and inflammatory mediators, those participating in inflammatory 
process of the ligamentous supporting structure and in resorption of alveolar bone, will 
be presented.
Keywords: periodontal diseases, immune response, cytokines, chemokines, immune 
cells
1. Introduction
Periodontitis is one of the most common and a complex infectious disease of the oral cavity. 
Studies suggest that up to 60% of the population is affected by the common form of the  disease, 
termed chronic periodontitis. Periodontitis is a multifactorial disease, with participation of 
bacterial, environmental, and host factors. The disease is characterized by an inflammatory 
response to commensal and pathogenic oral bacteria. Due to bacterial infection, gingival  tissues 
become inflamed, characterizing gingivitis, and if left untreated, periodontal supporting tis-
sues can be slowly destroyed by the action of the inflammatory process, which characterizes 
periodontitis. In the course of periodontitis, teeth lose their ligamentous  supporting structure 
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to the alveolar bone, the alveolar bone is resorbed, and the teeth become mobile. In its severe 
form, it may lead to tooth loss. 
There are two major forms of periodontitis, chronic periodontitis (CP) and aggressive peri-
odontitis (AP). CP is a slowly progressing disease, which can be categorized as mild/early, 
moderate or severe based on clinical criteria, such as probing pocket depth (PPD) and clinical 
attachment loss (CAL). AP occurs in 1–3% of the population and is characterized by rapid rate 
of disease progression in an otherwise clinically healthy patient, absence of large accumula-
tions of plaque, and familial inheritance. 
Traditional and fundamental procedures for diagnosis of periodontitis include visual exami-
nation, tactile sensation, PPD, CAL, plaque index, bleeding on probing, and radiographic 
assessment of alveolar bone loss. Periodontal bleeding reveals the ulcerated area of subgin-
gival tissue, whereas probing depth reveals the extent of the area of tissue covered by sub-
gingival biofilm. Although different estimates for quantification of the area of periodontal 
injury have been reported in the literature, the inflammatory challenge of periodontal disease 
usually consists of an affected area of 15–72 cm2 [1].
Bacteria have been considered to be the initiating factors to trigger periodontitis. Especially, 
Gram-negative anaerobic bacteria including Porphyromonas gingivalis (P. gingivalis) and 
Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans) have been strongly impli-
cated in disease. Localized aggressive periodontitis is associated with A.  actinomycetemcomitans, 
while generalized forms of chronic disease involve P. gingivalis, and also Tannerella forsythia, 
Prevotella intermedia, Treponema denticola, and Fusobacterium nucleatum (F. nucleatum) [2]. 
P. gingivalis has been implicated to be one of the most important periodontal pathogens, and 
its important features in mediated CP include the ability to adhere to and invade host cells, to 
disseminate through host cells and tissues, and to subvert host immunological defense mech-
anisms. The cell wall components of P. gingivalis, especially lipopolysaccharide (LPS), can 
cause direct destruction of periodontal tissues and trigger a wide range of immune responses, 
including the production of proinflammatory cytokines, antiinflammatory cytokines and 
chemokines, which might be important in periodontitis development [3]. A distinct systemic 
response was observed among different strains of P. gingivalis in vivo: strains that induced 
expression of high levels of IL-4 were shown to induce alveolar bone loss, whereas strain that 
increased IL-10 did not significantly promote bone resorption in mice [4].
Current evidence supports the importance of several factors increasing onset and progression 
of periodontal diseases, including smoking, diabetes, hormonal changes, and osteoporosis. 
Other potential interactions with periodontal disease are those involving obesity, adverse 
pregnancy outcomes, cardiovascular diseases, psychosocial factors and socioeconomic 
status [5]. 
In this way, the aim of this chapter is to summarize the role of innate and specific immune 
response involved in pathogenesis of chronic periodontitis. The neutrophils, monocytes/ 
macrophages, and T and B lymphocytes and inflammatory mediators, including cytokines, 
those participating in inflammatory process of the ligamentous supporting structure and in 
resorption of alveolar bone, will be discussed.
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2. Immunopathogenesis of chronic periodontitis
The host response during periodontitis involves the innate and adaptive immune system, 
leading to chronic inflammation and progressive destruction of tooth-supporting tissues. 
The pathogenesis of periodontal disease involves a complex interplay between periodonto-
pathogens and the host immunity, greatly influenced by genetic and environmental factors 
(as smoking). Dental plaque is necessary, but not sufficient for disease, where an exacerbated, 
poorly specific and effective inflammatory response is mounted. Failure in the inflammation 
resolving mechanism leads to establishment of a chronic inflammatory process, resulting in 
the destruction of bone and soft tissue. 
The host inflammatory response is mediated mainly by neutrophils, monocytes/macrophages, 
and T and B lymphocytes. Neutrophils are the first cells to arrive at the inflammatory infiltrate. 
The innate response involves the recognition of microbial components by Toll-like receptors 
(TLRs) expressed by host cells in the infected microenvironment. When the resolution of 
inflammation is not achieved, antigen-presenting cells are activated by bacterial products and 
interact with naïve T helper cells (Th0), driving their differentiation into several subsets, such 
as Th1, Th2, Th17, and Treg. T lymphocytes are central to adaptive immunity and provide 
help for B cells to generate specific antibodies. T cell receptor recognition of peptide antigen in 
the context of major histocompatibility complex can result in CD4 T cells activation. Activated 
Th0 may differentiate into either Th1 lymphocytes expressing Interleukin (IL)-2, interferon-
gamma (IFN-γ), and tumor necrosis factor-alpha (TNF-α); or Th2 lymphocytes, expressing 
IL-4, IL-5, and IL-13; or Th17 expressing IL-17A, IL-17F, IL-21, and IL-22. Activated and effec-
tor T cells may become memory T cells. T regulatory (Treg) cells are responsible for mecha-
nisms of tolerance: the T cells CD4+ CD25+ have been shown to be higher in periodontitis than 
gingivitis, suggesting the importance of immunoregulation in periodontitis.
2.1. The innate immune response
The innate immune response constitutes the first line of defense and is able to recognize non-
self microorganisms trigging immune response to eliminate them. 
Unlike adaptive immunity, innate immunity does not recognize every possible antigen. 
Instead, it recognizes a few highly conserved structures present in many different microorgan-
isms such as LPS, peptidoglycans, bacterial DNA, double-strand RNA, N-formylmethionine 
found in bacterial proteins, the sugar mannose and proteases (named pathogen-associated 
molecular patterns, PAMPs). The defense cells have pattern-recognition receptors (PPRs) for 
these PAMPs and trigger immediate response against the microorganism. PPRs are found 
on inflammatory cells and on periodontal tissue resident cells, such as epithelial cells (ECs), 
gingival fibroblasts (GFs), periodontal ligament fibroblast (PDLF), dendritic cells (DCs), and 
osteoblasts (OBs). These receptors include TLRs, nucleotide-binding oligomerization domain 
(NOD) proteins, cluster of differentiation 14 (CD14), complement receptor-3, lectins, and 
scavenger receptors. PAMPs can also be recognized by a series of soluble pattern-recognition 
receptors in the blood that function as opsonins and initiate the complement pathways. 
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After bacterial challenge, the resident cells recognize PAMPS, via TLRs, and initiate an 
orchestrated signaling events resulting in the production of proinflammatory cytokines and 
chemokines, and recruitment of inflammatory cells. The TLR4 has been shown to specifi-
cally recognize LPS from gram-negative bacteria. Cytokines, such as tumor necrosis factor-α 
(TNF-α), interleukin (IL)-1β and IL-6, within periodontal lesions, orchestrate the cascade of 
destructive events that occur in the periodontal tissues. These events include the production 
of inflammatory enzymes and mediators (such as matrix metalloproteinases and prostaglan-
dins), and osteoclast recruitment, and differentiation through receptor activator of nuclear 
factor-κβ ligand (RANKL)-dependent and -independent pathways resulting in irreversible 
hard and soft tissue damage and in chronic periodontitis.
These cells involved in innate response and molecular factors involved in the local inflamma-
tory reaction will be discussed later.
2.1.1. Cells involved in innate immune response
2.1.1.1. Neutrophils and monocytes/macrophages
Neutrophils, also called polymorphonuclear leukocytes (PMN), are one of the first respond-
ers of inflammatory cells to migrate toward the site of periodontal inflammation. The nucleus 
of neutrophils is segmented into three to five lobules, and the cytoplasm contains granules of 
two types: specific granules which are filled with enzymes such as lysozyme, collagenase, and 
elastase; and azurophilic granules which are lysosomes containing microbicidal substances 
as enzymes, defensins and cathelecidins. After periodontal pathogens successfully overcome 
epithelial barriers and invade soft tissues, signals from bacteria and gingival epithelial cells, 
human mesenchymal stem cells, connective fibroblast, and resident macrophages induce the 
production of cytokines and chemokines by the gingival epithelium. The chemoattractant 
molecules (such as IL-8 and IL-1β, and serum-derived plaque activated C5a) increase the 
expression of adhesion molecules, the permeability of gingival capillaries, and the migration 
of neutrophils through the junctional epithelium and into the gingival sulcus [6].
The interaction between the oral microbiota and neutrophils is a key determinant of oral 
health status. Neutrophils form a “wall” between the junctional epithelium and the patho-
gen-rich dental plaque providing a robust secretory structure (reactive oxygen species [ROS] 
and bactericidal proteins) and a phagocytic apparatus. However, this protection is not with-
out cost because neutrophils from periodontitis patients are hyperreactive and contribute 
to tissue destruction: ROS and the enzymes released by cytoplasmic granules degrade the 
structural elements of tissue cells and extracellular matrix and cause tissue damage [7, 8]. 
A recently discovered innate defense strategy of neutrophils is the release of DNA to the 
extracellular environment, where the web-like DNA threads trap and kill microorganisms 
by means of DNA-bound antimicrobial proteins and peptides. These neutrophil extracellular 
traps (NETs) are also known to arise in periodontal tissues and purulent pockets. NETs rep-
resent a host defense mechanism but may also cause host tissue injury [9]. On the other hand, 
alterations in neutrophils function result in an acute, severe, and generalized clinical phe-
notype of periodontitis. These alterations can involve different functions, such as adhesion 
capabilities, chemotaxis response, and phagocytic function [10]. Added to this, neutrophils 
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with normal functions in individuals with alterations in the IL-8 production and/or mutations 
in Duffy antigen receptor chemokines (DARC) expression on erythrocytes predispose those 
individuals to periodontitis [11]. It occurs because adsorption of IL-8 onto erythrocytes by 
DARC leads to an increased recruitment of leukocytes from the blood to the tissue compared 
to individuals without DARC on the erythrocytes.
Monocytes/macrophages belong to mononuclear phagocytes system. They are also important 
innate immune cells at infection sites in patients with CP. These cells produce large amounts of 
proinflammatory cytokines, antiinflammatory cytokines, and chemokines, including TNF-α, 
IL-1β, IL-8, and IL-10. These chemokines produced by these cells attract neutrophils; however, 
neutrophils also produce chemokines, which attract macrophages to inflamed periodontal site. 
Thus, a crosstalk exists between these innate cells. Macrophages are important in triggering 
the specific immune response serving as antigen-present cells that display antigens to and acti-
vate T lymphocytes. Added, monocytes/macrophages can differentiate into osteoclasts [12].
2.1.1.2. Fibroblasts
Periodontal ligament fibroblast (PDLF) and gingival fibroblasts (GF) are the main cells of 
the soft connective tissue. In conjunction with infiltrating inflammatory cells, GFs take part 
in the inflammatory process in the periodontium and contribute to the disease persistence. 
After microorganisms breach the epithelial barrier, these cells produce cytokines and deg-
radation molecules. Expression of matrix metalloproteinases (MMPs) became accentuated. 
Fibroblasts from periodontitis patients expressed higher mRNA of IL-1β, IL-6, and TIMP-3 
and lower mRNA of IL-4 [13]. PDFL also produces IL-8, TNF-α, macrophage inflammatory 
protein (MIP)-1 alpha, and receptor activator of nuclear factor-κβ ligand (RANKL), which are 
regulators on inflammation and alveolar bone loss. When in cell-cell contact with osteoclast 
precursors, PDFL upregulated osteoclastogenesis-related genes and significantly increased 
the number of osteoclast-like cells [14].
2.1.1.3. Dendritic cells
Dendritic cells (DCs) are the most important antigen-present cells for activating naïve T cells. 
These cells function in both innate and adaptive immune responses and are a link between 
these two components of host defense. They are part of myeloid lineage and arise from the 
same monocyte precursor. DCs have long membrane projections and phagocytic capabilities. 
Similar to macrophages, they express receptors that recognize bacteria and respond by secret-
ing cytokines. They produce IL-12 and IL-18 that consequently promote interferon-gamma 
(INF-γ) secretion by natural killer (NK) cells and latter by T cells. In response to activation 
by microorganism, conventional DCs become mobile, migrate to lymph nodes, and display 
antigens to T lymphocytes.
2.1.2. Molecular factors involved in the local inflammatory reaction
In the innate immune response, the bacterial activation of resident cells culminates in a pro-
duction of proinflammatory cytokines involved in periodontal immunopathogenesis. In order 
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to eliminate the bacteria, the inflammatory process is triggered; however, the inflammation 
culminates in periodontal tissue lesions and alveolar bone resorption [15].
2.1.2.1. Toll-like receptors (TLRs)
TLRs play an important role in the recognition of pathogens. TLRs are a family of trans-
membrane proteins expressed by immunologically competent cells. They recognize and bind 
to PAMPs derived from bacterial plaque. TLRs are evolutionarily conserved proteins with 
a highly conserved intracellular toll-interleukin receptor (TIR) domain involved in protein- 
protein interaction and signaling activation. The extracellular domain, with leucin-rich repeats 
(LRRs) is related to ligand recognition. LRR motifs vary among TLRs. After PAMPs recogniz-
ing, TLRs initiate the activation of several transcription factors including nuclear factor-kappa 
B (NF-κB) and activator protein 1 (AP-1) through the mitogen-activated protein kinase (MAK) 
cascade. NF-κB is a key transcription factor complex that appears to play a critical role in the 
regulation of an acute inflammation. NF-κB enters the nucleus of the cell and induces expres-
sion of proinflammatory mediators including adhesion molecules (ICAM-1, VCAM-1, and 
E-selectin), enzymes (COX-2, 5-LO, CPLA, and iNOS), cytokines (IL-1, TNF, IL-6, GM, and 
G-CSF), and chemokines (IL-8, RANTES, MCP-1, eotaxin, and MIP-1κ). An increase in the 
recruitment of leukocytes is generated [16, 17].
TLR-2, 3, 4 and 9 are much expressed in gingival tissues of periodontitis patients, and TLR-2 
and TLR-4 expressions are increased in severe disease states, suggesting that these receptors 
have an increased capacity to signal and influence downstream cytokine expression. TLR-4 
is present on antigen presenting cells, fibroblasts, and keratinocytes of gingival epithelium. 
TLR4 has been shown to specifically recognize LPS from gram-negative bacteria and thus 
recognize PAMPs of periodontopathogens such as P. gingivalis, A. actinomycetemcomitans¸ 
and V. parvula. Tool-like receptor-4 acts in cooperation with its coreceptors CD14 protein and 
MD-2 complex, as well as TLR4 adaptor proteins such as myeloid differentiation primary 
response gene 88 (MyD88) playing an important role in maintenance of periodontal healthy. 
However, over production of proinflammatory cytokines due to chronic stimulation of TLRs 
may lead to tissue damage. LPS-triggered TLR4 activation leads to an increased secretion of 
proinflammatory cytokines, mediators and matrix metalloproteinases (MMPs) from a variety 
of cells including monocytes, macrophages, neutrophils, lymphocytes, and gingival fibro-
blasts. Repeated stimulations of these receptors may also lead to development of tolerance to 
bacterial products. TLR-2 engagement has been shown to trigger production of proinflamma-
tory and antiinflammatory cytokines [18, 19].
CD14 is a myeloid differentiation marker found primarily on monocytes and macrophages, 
although low levels are also found on neutrophils and endothelial cells. CD14 is a coreceptor 
for LPS. The CD14 gene is located on chromosome 5q31.3 and encodes two forms of protein: 
one is anchored to the membrane glycosylphosphatidylinositol (mCD14) and is a 55-kDa gly-
coprotein, and another is a soluble form (sCD14) found in body fluids. CD14 lacks the trans-
membrane domain and is unable to transmit LPS signaling. The major function of CD14 is to 
serve as an initial receptor for LPS and facilitate the binding of LPS to TLR4/MD-2 complex. In 
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addition, CD14 also recognizes other PAMPS such as lipoteichoic acid. Proinflammatory and 
antiinflammatory effect of CD14 has been shown indicating dual roles in response to Gram-
negative bacteria [20, 21].
2.1.2.2. Matrix metalloproteinases (MMPs)
The matrix metalloproteinases (MMPs) are a structural and functional family of zinc- 
dependent extracellular proteinases, which are responsible for the remodeling and deg-
radation of tissue extracellular matrix (ECM), including collagens, elastins, gelatin, matrix 
glycoproteins, and proteoglycans. To date, at least 26 members of MMPs have been identi-
fied and they are grouped according to their structural properties and substrate specificity 
in collagenases (MMP-1, -8, -13, -14), gelatinases (MMP-2 and -9), stromelysins, matrily-
sins, and membrane type matrix metalloproteinases. The balance between MMPs and their 
endogenous inhibitors (tissue inhibitor of matrix metalloproteinases, TIMPs) controls the 
MMP activity. MMPs play an important role in tissue degradation observed in periodonti-
tis, and elevated levels of MMP-1, -2, -3, -8, and -9 have been detected in gingival crevicular 
fluid, peri-implant sulcular fluid, and gingival tissue of periodontitis patients. MMP-1 is 
produced by periodontal resident cells and is considered as central in the physiological 
remodeling of extracellular matrix in wound healing. MMP-8, mainly produced by neutro-
phils, is associated to periodontal collagen destruction and represents the major collagenase 
in gingival and crevicular fluids; its levels can differentiate periodontitis from gingivitis 
and healthy sites. MMP-9 has been associated with collagen breakdown and periodontal 
inflammation. MMP-13 is little or not expressed on normal tissues, but its upregulation 
has been involved in periodontitis progression and bone loss. MMPs can be released or 
activated during periodontal disease by proinflammatory cytokines, as TNF-α and IL-1β, 
reactive oxygen species, and proteases; IL-18 may be related to be involved in the regulation 
of MMPs [22–24].
2.1.2.3. Cytokines
The resident cells and migrating cells release cytokines during inflammatory response involv-
ing in chronic periodontitis. Endothelial cells and GF produce IL-8, a chemokine that is neu-
trophils chemoattractant and that increase the monocytes adhesion. Neutrophils (the migrant 
cells) and PDLF produce IL-1, IL-6, and TNF-α. GF also produces IL-6 and TNF-α. PDLF and 
also bacterial antigens could promote the expression of the RANKL by the osteoblasts. DC 
IL-12p40, IL-18, IL-6, and TGF-β (transforming growth factor beta) act as antigen-present cells 
to T lymphocytes. The role of this cytokines will be described later.
After this initial primary response, activation of T cells by APCs initiates the adaptive 
response. Subsequently, the effector mechanisms of innate immunity are improved by adap-
tive immunity involving an efficient loop for microbial clearance. Chronic periodontal inflam-
mation perpetuates and amplifies itself through numerous autocrine and paracrine loops of 
cytokines, acting on cells within the periodontal tissue.
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2.2. The adaptive immune response
When the resolution of inflammation is not achieved, adaptive immune response is initiated. 
Therefore, APCs are activated by bacterial products and interact with naïve T helper cells 
(CD4 T cells, Th0: CD45RA+), driving their differentiation into several subsets (CD45RO+), 
such as Th1, Th2, Th17, and Treg. Adaptive immune cells and their cytokines have important 
participation in pathogenesis of the chronic periodontitis, including the resolution of infec-
tion, tissue damages, and osteolytic process. 
2.2.1. T cell subsets enrolled in the pathogenesis of CP
For a long time, periodontitis lesions were conceptually defined based on a Th1/Th2 para-
digm. Currently, Th1 and Th2 responses, added to the Th17 subset, have been related to the 
disease progression and bone resorption. T cell lymphocytes (CTLs) are primarily involved 
in the cell-mediated immunity. CTLs were named because their precursors, which arise in 
the bone marrow, migrate and maturate in the thymus. The two major T cell subsets are CD4 
(T helper) and CD8 CTLs, which express a highly diverse and clonally distributed antigen 
receptor called the αβ receptor. Both effector cells usually express surface protein indicative 
of recent activation, such CD25, a component of the receptor for the T cell growth factor IL-2. 
Th cells express surface molecules as CD40 ligand (CD154) [25].
2.2.1.1. T-helper 1 (Th1 cells)
Th1 cells are generated under the influence of interleukin-12 and/or interferon-γ (INF-γ) sig-
naling that leads to the activation of the transcription factor T-bet. In diseased gingival tissues, 
Th1 cells have been predominant. Activated Th1 cells secret INF-γ, present in high levels in 
human and experimental periodontal lesions. INF-γ is associated to onset and progression 
of lesions. Besides, INF-γ stimulates osteoclast formation and bone loss via antigen-driven T 
cell activation or through the chemoattraction of RANKL cells. Also, INF-γ can contribute to 
the migration of CD4/80+ cells, monocyte/macrophage-like phenotypes, a potential osteoclast 
precursor subpopulation [26, 27].
2.2.1.2. T-helper 2 (Th2 cells)
Th2 cells are generated under the influence of interleukin-4 and the activation of the transcrip-
tion factor GATA-3. IL-4 secreted by Th2 exhibits antiinflammatory and suppressive proper-
ties related to the induction of IL-10 and suppression of Th1 response. In pathogenesis of 
periodontitis, it can be associated with the ability to inhibit the production of tissue degrading 
factors such as MMPs and the major osteoclastogenic factor RANKL. Therefore, IL-4 could 
attenuate the soft and mineralized tissue destruction. However, IL-4 levels were found lower 
in crevicular fluid from periodontitis patients.
Added to this fact, Th2 cells could be related to B cell function and humoral immunity in the 
periodontal lesion. B cells seem to contribute to periodontal disease development since B cell 
deletion prevented alveolar bone loss in mice after infection with P. gingivalis and because 
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the majorly of B cells in periodontal lesions are RANKL+ [28]. IgG is the more frequent anti-
body class present in the gingival crevicular fluid and gingiva of patients with periodontitis; 
therefore, IgA and IgM are also found. IgM and IgG classes were related to autoimmunity in 
periodontitis where high titers of anticollagen type I, antifibronectin and antilaminin were 
found [26, 27].
2.2.1.3. T-helper 17 (Th17 cells)
Th17 cells are generated under the influence of IL-6/IL-21/IL-23/TGF-β and the activation 
of the transcription factor RORγT. After TGF-β and IL-6 driver Th17, IL-23 amplifies the 
 phenotype. Th17 cells have been linked to the development of pathological inflammatory 
disorders. Cytokines secreted by Th17, such as IL-17 and IL-22 are crucial for host protec-
tion against many extracellular pathogens. Furthermore, IL-17 contributes to innate and spe-
cific immunity by recruiting inflammatory cells and immobilizing macrophages in inflamed 
 tissue. The consequence is an abundance of other inflammatory cytokines as IL-1β and TNF-
α, and RANKL. Th17 cells have been linked to several autoimmune disorders and are also 
linked to the development of pathological inflammatory disorders, and their presence was 
demonstrated in the gingival tissue from patients with periodontitis [29, 30].
2.2.1.4. T regulatory cells (Treg cells)
Treg cells are generated under the influence of IL-10/TGF-β and the activation of the tran-
scription factor forkhead box P3 (FOXp3). They also expressed as a αβ antigen receptor. Treg 
cells specifically regulate the activation, proliferation, and effectuating functions of activated 
T cells. There are two types of Treg: (i) endogenous or natural (Treg), which are derived 
from the thymus and control autoreactivity; (ii) adaptive or induced (aTreg or iTreg), which 
regulate responses upon antigenic exposure in the periphery. In noninflammatory tissues, 
they are in resting state. The cytokines TGF-β, IL-10, and cytotoxic T lymphocyte-associated 
molecule 4 (CTLA-4) are supposed to mediate the suppressive activity in peripheral tissues 
and attenuate periodontal diseases progression and protect the bone resorption. Treg cells are 
shown to attenuate RANKL expression by other activated T cells. Treg cells were identified 
in periodontal tissues; however, deficiency of Treg cells was observed in periodontitis [31].
Another subset of Treg cells includes the Tcreg. In animal models and under noninflamma-
tory conditions, murine osteoclasts can recruit naïve CD8 T-cells and activate these T-cells to 
induce CD25 and FoxP3 (Tcreg). Tcreg can potently and directly suppress bone resorption by 
osteoclasts. The activation of CD8 T cells by osteoclasts also induced the cytokines IL-2, IL-6, 
IL-10, and interferon (IFN-c). Individually, these cytokines can activate or suppress osteoclast 
resorption [32].
2.2.1.5. T CD8 cells
After naïve cells are activated, they became larger and proliferate, and are called lympho-
blasts. Some of these cells differentiate into CD8 CTLs. CD8 cells have cytoplasmic granules 
filled with proteins that, when released, kill the cells that the CDLs recognize. They are also 
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called cytotoxic T cells. In an animal models, which allow investigating the stages of peri-
odontitis, CD8 T cell knockout mice showed no significant change in bone loss after infection 
with P. gingivalis [33].
The activated T helper subsets, their produced cytokines and their general functions are sum-
marized in Table 1.
2.2.2. The adaptive immunity in the pathogenesis of chronic periodontitis
Adaptive immune responses to most immunogens can begin only after the immunogen has 
been captured, processed, and presented by an APC to naïve T helper cells. The reason of this 
is that T cells only recognize immunogens that are bound to major histocompatiblity complex 
(MHC) proteins on the surfaces of other cells. There are two different classes of MHC pro-
teins. Class I MHC proteins are expressed virtually in all somatic cell types and are used to 
present substances to CD8 T cells. Class II MHC proteins, on the other hand, are expressed 
only by macrophages, dendritic cells and a few other APCs, and are necessary for antigen 
presentation to T helper cells. The interaction of APC-T cells is dependent on other membrane 
receptors. The TCR complex confers specificity because it contains the antigen-specific recep-
tor. The interaction is enhanced through coreceptors including CD27, CD28, CD40 ligand, or 
inhibited by coinhibitor receptors such as CTLA4, programmed cell death protein (PD1), and 
CD28 induced costimulator (ICOS) [25].
Stimulating 
cytokines
Differentiated 
T cells subsets 
and respective 
transcriptional 
factors (italic)
Produced 
cytokines *
Regulatory 
cytokines
Host defense General roles in 
diseases
Naive TCD4 T 
cells
IL-12
IL-18
INF-γ
T
H
1
T-bet, STAT1, 
STAT4
INF-γ
LTA
RANKL
IL-4
IL-10,
TGF-β
Intracellular
pathogens
Tissue damage 
associated 
with chronic 
infections
IL-2
IL-4
T
H
2
GATA-3, STAT6
IL-4
IL-15
IL-13
INF-γ
TGF-β
Extracellular
pathogens
Humoral 
immunity
Allergic 
diseases 
Autoimmune 
diseases
IL-6
TGF-β
T
H
2
2AHR
IL-22 TGF-β Extracellular
pathogens
IL-6
TGF-β
IL-21
T
H
17
RORγT, STAT3
IL-2
IL-4
IL-27
INF-γ
Homeostasis at 
mucosal sites/ 
inflammation
Organ-specific 
autoimmunity
*The cytokines produced by these T cells subsets determine their effector functions and roles in diseases. The cytokines 
also participate in development and expansion of the respective subsets.
Table 1. T cell subsets differentiation and general functions in immune response.
Periodontitis - A Useful Reference152
The acquired immune response is known to be important for periodontal disease develop-
ment. Specific microbial components activate APCs, such as DC, and both migrate to local 
lymph nodes. In APC, immunogen become enclosed within membrane-lined vesicles in the 
cytoplasm and within these vesicles, undergo a series of alterations called antigen processing 
and a limited number of the resulting peptides are noncovalently associated to MHC class II 
proteins, and transported to APC surface, where it is detected by CD4 T cells. After specific 
antigen recognition, activation phase is initiated by the sequences of events induced in lym-
phocytes. The Th0 differentiation is dependent of the local cytokine milieu. Then, the CTL 
proliferate, leading to expansion of the clones of antigen-specific CTL and the amplification 
of the response. The pattern of cytokines expressed determines subsequent polarization of a 
distinct antigen-specific CTL response. Next, CTL differentiates to cells that function to elimi-
nate foreign antigens: some T cells (CD4) differentiate into cells T helper subsets, that activate 
phagocytes to kill intracellular antigens, or in others T cells (CD8) that directly lyses cells that 
are producing foreign antigens, and also B cells, which transform to plasma cells that secreted 
specific antibodies. The effector phase is the stage that leads to antigen elimination. In this 
phase, inflammatory response is amplified after recruitment of specific and nonspecific effec-
tor cells (lymphocytes, macrophages, neutrophils) and their soluble products (lymphokines, 
monokines, complement, kinines, arachidonic acid derivates, mast cells—basophile products).
Characteristic markers of Th1, Th2, Th17 and Treg cell subsets have all been described in 
diseased periodontal tissues. Therefore, the exact crosstalk that occurs among Th cytokines in 
periodontal disease and its impact on disease outcome is still to be determined. However, it is 
clear that Th cells are essential for periodontal destruction because the absence of B cells does 
not impede LPS-induced bone resorption.
There are tissue resident memory cells within the oral mucosa. When compared with primary 
immune response, the recall of memory is faster and shows fewer requirements for antigen 
presentation by MHC and costimulation. In gingival tissues, IL-15 is found in abundance and 
seen to be responsible for the survival and proliferation of memory cells.
2.3. Cytokines in the pathogenesis of chronic periodontitis
Cytokines are low molecular weight water-soluble glycoprotein secreted by hematopoietic 
and nonhematopoietic cells in response to infection, and they are important key molecules 
and signal mediators in the pathogenesis of periodontitis. The cytokines involved in immuno-
pathology of periodontal disease act in a highly complex coordinated network and play role 
in the maintenance of specific leucocytes on periodontal tissue, in the osteoclastogenesis acti-
vation and stimulation of bone resorption. Several of the cytokines have been demonstrated to 
serve either as proinflammatory (IL-1, IL-12, IL-17, IL-18, TNF-α) or antiinflammatory (IL-4, 
IL-10) mediators of the inflammatory process [34].
2.3.1. Interleukin-1 (IL-1)
IL-1 is a potent proinflammatory mediator and bone-resorbing cytokine formerly known 
as the osteoclast-activating factor. The IL1 gene cluster is located on chromosome 2q13–q21 
Immunopathogenesis of Chronic Periodontitis
http://dx.doi.org/10.5772/intechopen.69045
153
(https://www.ncbi.nlm.nih.gov/gene/3553) [35]. In the IL-1 superfamily members, two ago-
nists and one antagonist members are highlighted: IL-1α and IL-1β (proinflammatory cyto-
kines), and IL-1/IL-receptor antagonist (antiinflammatory cytokine). Between them, IL-1β is 
the most studied due its role in immunoinflammatory diseases. IL-1β, even as IL-1α, is able 
to bind and activate interleukin-1 receptors resulting in the recruitment of several intracellu-
lar adapter molecules, including MyD88, NFκB, AP-1, and mitogen activated protein kinase 
(MAPks). This interaction leads to transcription of genes of intercellular adhesion molecule-1 
(ICAM-1) that incites the innate immune response, and genes of lymphocyte function associ-
ated antigen-1 (LFA-1) that culminates in a greater migration of leukocytes in tissue direction. 
Once secreted, IL-1 may activate lymphocytes, incite macrophage chemotaxis and prostaglan-
din production, and stimulate osteoclastic resorption of bone [36, 37].
In periodontitis, IL-1 is detected in the periodontal tissue and in the gingival crevicular 
fluid and is important in the metabolism of collagen, in bone destruction, and other inflam-
matory processes. IL-1β is secreted mainly by macrophages and resident cells. IL-1 could 
mediate the gingival and periodontal tissue destruction and bone resorption by different 
ways: (i) IL-1β and IL-1α stimulate the release of lysosomal enzymes such as metallopro-
teinase which degrades the extracellular matrix; (ii) IL-1β stimulates the production of 
prostaglandin E2 (PGE2) by fibroblasts and osteoblasts (OB). PGE2 stimulates bone resorp-
tion mediated by RANKL expression in OB; and (iii) IL-1β enhances RANKL expression on 
OB [38–40].
2.3.2. Tumor necrosis factor: alpha (TNF-α)
TNF-α is a very potent proinflammatory cytokine with a pleotropic effect on both immune 
and skeletal systems. It is encoded by TNF gene located on chromosome 6 (https://www.ncbi.
nlm.nih.gov/gene/7124) [41] and is primary produced by activated T cells, monocytes/macro-
phages, and fibroblasts during inflammation. It is expressed as a transmembrane protein with 
26 kDa or as a soluble TNF form with 17 kDa. When binding in the TNF receptors, TNF-RI 
of 55-kDa or TNF-RII of 75-kDa, the intracellular signaling pathways are activated via c-Jun, 
NF-kB, and calcium signaling leading to biological cellular response of inflammation. This 
response includes: (i) increase of adhesion molecules for leukocytes, as ICAM-1 and E-selectin; 
(ii) recruitment of leukocytes; (iii) increase of vascular permeability; (iv) increase the produc-
tion of metalloproteinase and proinflammatory cytokines; and (v) osteoclasts differentiation 
dependent and independent of RANKL. The inappropriate or excessive TNF-α production can 
be harmful to tissue [42, 43].
TNF-α was detected in higher levels in saliva and crevicular fluid of patients with periodontal 
disease and its role and contribution to inflammation, loss of connective tissue attachment, 
and alveolar bone resorption has been well documented [44].
2.3.3. Interleukin-6 (IL-6)
IL-6 is a pleiotropic cytokine not only exerting immunological effect but also functioning in 
hematopoiesis, bone metabolism, and tissue regeneration. The human IL6 gene is located in 
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the short arm of chromosome 7 (7p21; https://www.ncbi.nlm.nih.gov/gene/3569) [45]. IL-6 is 
a cytokine produced by T cells, B cells, monocytes/macrophages, endothelial cells, GF, OB 
and, periodontal ligament cells. It has multifunctional properties and is secreted in response 
to bacterial LPS or IL-1β and TNF-α stimulus. The IL-6 binding receptor (IL-6R) is located 
in membrane of cells and dimerizes with two gp130 subunits when IL-6 binds. Besides this, 
there is also a soluble form of receptor, and both receptors when activated are able to pro-
mote biological effects into the cells. IL-6 in promoting inflammation, it can also be involved 
in the regulation of tissue destruction. IL-6 induces the production of inhibitors of MMPs, 
suppresses IL-1β and TNF-α expression, and induces IL-1 receptor antagonist. Another posi-
tive point that favors the reduction of tissue damage is that IL-6 can stimulate fibroblasts 
to produce collagen and glycosaminoglycan. IL-6 plays role in B cells differentiation, T cell 
proliferation, and acute phase proteins expression. In addition, IL-6 in synergism with TNF-α 
is able to induce the differentiation of osteoclast progenitors directly or stimulate the stromal 
cells to produce RANKL.
This cytokine exerts an important effect in the pathogenesis of periodontitis, mainly in bone 
metabolism. During the development of CP, multiple biological actions could be mediated 
by the IL-6, including hematopoiesis, angiogenesis induction, immunocyte activation, and 
osteoclast differentiation. The presence of IL-6 in serum, gingival crevicular fluid, and saliva 
suggested an altered production of IL-6 in patients with CP [46, 47].
2.3.4. Interleukin-17 (IL-17)
The IL-17 family contains six members: IL-17A, IL-17B, IL-17C, IL-17D, IL-17E (or IL-25) and 
IL-17F, and five receptors, IL-17RA-RD and SEF. Interleukin-17A is most homologous to 
IL-17F and the genes encoding them are proximally located on chromosome 6p12 (https://
www.ncbi.nlm.nih.gov/gene/3605). The IL-17F activity is similar to IL-17A, but significantly 
weaker, and is related to induce the expression of various cytokines, chemokines, matrix 
metalloproteinases, antimicrobial peptides, and adhesion molecules by human fibroblasts, 
and airway epithelial cells and vein endothelial cells. IL-17A, IL-17B, IL-17C, IL-17D, and 
IL-17F are considered proinflammatory cytokines, and IL-17E is believed to have antiinflam-
matory properties. IL-17A, IL-17F and IL-22 are involved in neutrophilia, tissue remodeling, 
tissue repair, and production of antimicrobial products [48].
Many studies have demonstrated the presence of IL-17 in periodontal tissues, crevicular 
gingival fluid, saliva, and plasma of patients with periodontal disease. IL-17 contributes 
to inflammatory bone pathology and bone resorption by different ways: (i) stimulating the 
production and expression of TNF-α and IL-1β by human macrophages and IL-1β by OB; 
(ii) stimulating secretion of IL-6, CXCL8/IL-8, and PGE2 by fibroblasts, epithelial, and endo-
thelial cells; (iii) increasing the expression of RANKL on OB; and (iv) stimulates the dif-
ferentiation and activation of OC. In periodontal environment, IL-17 potentiates the innate 
immunity, mobilizing macrophages and neutrophils, and increasing TLR responsiveness in 
gingival epithelial cells. IL-17, when combined with IFN-γ, may modulate GF in periodontal 
disease by triggering the release of other proinflammatory, metalloproteinase and neutro-
phil-mobilizing cytokines [49].
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2.3.5. Interleukin-18 (IL-18)
IL-18 is a member of IL-1 cytokine family and is codified by IL18 gene located on chromo-
some 11q22 (https://www.ncbi.nlm.nih.gov/gene/3606) [50]. This proinflammatory cytokine 
is released at sites of chronic inflammation by APCs, such macrophages and DC, and non-
immune cells, such  epithelial and  osteoblastic stromal cells. Its receptor IL-18RC is complex 
with two chains, the IL-18Rα and the IL-18Rβ chains; and the β protein contains the motif for 
sign-transducing. IL-18 has the property of stimulating both Th1/Th2 responses, depending 
on the immunological context. When the IL-12 is present, IL-18 drives to Th1 response, and 
in its absence, the Th2 cells’ response is stimulated. IL-12 is able to increase the expression of 
IL-18Rβ. One of the major actions of IL-18 in Th1 response is to enhance the release of IFN-γ 
by TCD4+ cells and natural killer (NK). INF-γ acts as a positive regulator of Th1 differentiation 
through increased transcription of T-bet. In addition, proinflammatory properties of IL-18 are 
due to promotion of the increase of cell adhesion molecules, nitric oxide synthesis, and che-
mokines production. IL-18 induces the production of Th2 cytokines such as IL-4, IL-5, IL-10, 
and IL-13, stimulating allergic inflammation, and inducing PGE2 production [36, 51].
There are low evidences according IL-18 participation in periodontitis. Some studies show 
that IL-18 is an inhibitor of OC formation by indirect effects mediated by T cells and granu-
locyte macrophage colony-stimulating factor (GM-CSF). GM-CSF binds to preosteoclast and 
inhibits its proliferation and differentiation. The IL-18RC was found on T cells and OC. The 
concentration of IL-18 was found increased in the gingival crevicular fluid and serum of gin-
givitis, aggressive, and chronic periodontitis [52].
2.3.6. Interleukin-10 (IL-10)
IL-10 is considered an antiinflammatory cytokine playing a key role in the regulation of 
immune mechanisms. The IL10 gene (https://www.ncbi.nlm.nih.gov/gene/3586) is mapped 
on chromosome 1q31-q32, in a cluster with closely related interleukin genes, including IL-19, 
IL-20, and IL-24, and has several regulatory promoter sequences within the 1.3 kb region 
upstream of the transcription start site [53].
IL-10 is produced by monocytes, macrophages, and T cells and plays a role in the regulation of 
proinflammatory cytokines such as IL-1 and TNF-α. During bone loss, IL-10 was correlated to 
inhibition of OC formation direct and indirectly. Directly, IL-10 inhibits osteoclast progenitors 
by an effect associated with decreased RANK-induced activation of nuclear factor-kappaB 
and expression of NFATc1, c-Fos, and c-Jun. Indirectly, by decreasing RANKL and increasing 
osteoprotegerin in dental folic cells. IL-10 also had protective role toward periodontal tissue 
destruction, inhibiting MMPs. However, it has stimulatory effect on B lymphocyte and may 
also stimulate the production of autoantibodies. Autoantibodies may play a role in periodon-
titis. The high production of IL-10 by Treg was found in gingival tissue [54].
2.4. Immunopathogenesis of bone resorption
Skeletal homeostasis depend on a dynamic balance between the activities of the bone form-
ing osteoblasts (OB) and bone-resorbing osteoclast (OC). The RANK/RANKL/OPG  regulating 
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system controls the bone resorption and deposition activity that occur during this bone 
remodeling. The receptor-activator of nuclear factor-kappaB (NF-κB) ligand (RANKL) binds 
to RANK on osteoclast precursors (monocyte/macrophage) causing them to differentiate into 
active cells (OC) that secrete enzymes that degrade bone. OPG (osteoprotegerin) is a soluble 
decoy receptor of RANKL that prevents the RANK-RANKL interaction. OPG inhibits the 
osteoclastogenesis and induces osteopetrosis when overexpressed [55]. In periodontitis, high 
levels of RANKL and low levels of OPG have been detected in gingival crevicular fluid. In 
response to LPS from periodontopathogens, for instances P. gingivalis and A. actinomycetem-
comitans, RANKL expression has been increased in periodontal ligament fibroblasts; however, 
its major source is the activated immune cells, mainly Th1, Th17, and B cells [15, 56].
Several cytokines can synergize with RANKL in promoting osteoclastogenesis and increas-
ing RANKL/OPG ratio. Cytokines, such as IL-1, TNF-α, IL-6, and IL-17, have the ability to 
stimulate bone resorption, whereas others, such as IL-4, IL-10, and TGF-β, act as inhibitors. 
TNF-α and also IL-1 have been shown to play an important role in periodontal bone loss in a 
dependent and independent RANKL pathway: TNF-α could promote the proliferation and 
differentiation of osteoclast precursors via NFATc1 activation. TNF-α also could lead to inhi-
bition of OB differentiation. The TNF-related apoptosis inducing ligand (TRAIL) is expressed 
on OB after infection and induce the apoptosis of these cells. IL-17, when in high concentra-
tion, promotes osteoclastogenesis by enhanced RANKL expression on osteoblasts and CD4 
T cells [57, 58].
The immune cells and cytokines produced by them involved in the protective and aggressive 
roles during CP are summarized in Table 2.
Immune response Cells Characteristic 
produced cytokines*
Protective actions Deleterious actions
Innate immunity Neutrophils TNF-α
IL-1
IL-6
No evidence Proinflammatory RANKL 
inducers
PDLFs TNF-α
IL-1
IL-6
No evidence Proinflammatory RANKL 
inducers RANKL+
Monocyte/
macrophage
No evidence Proinflammatory RANKL 
inducers OC differentiation
Adaptive immunity TH1 INF-γ Antiosteoclastogenic Proinflammatory RANKL+
TH2 IL-4 Antiosteoclastogenic B cells lesions and autoimmunity B RANKL+
TH17 IL-17 No evidence Proinflammatory RANKL inducers RANKL+
Tregs IL-10
TGF-β
Antiosteoclastogenic No evidence
PDLFs: periodontal ligament fibroblasts; OC: osteoclasts.
Table 2. Immune cells and their characteristic cytokines involved in tissue damage and bone resorption in chronic 
periodontitis.
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3. Immunomodulation and therapeutic approaches
Therapeutic approaches in periodontitis attempt to eliminate the periodontal plaque, manage 
the inflammation and minimize the tissue damage. The conventional treatment of CP is the 
mechanical removal of infectious agents in gingival tissues, which resulted in bacteria resis-
tance and disease recurrence. Considering the complexity of periodontitis, immunopathogen-
esis and clinical manifestations of disease, many different approaches could be considered in 
order to interfere during immunity response. Amongst them, blocking the cytokines activity 
may be a promissory intervention. The effect of TNF-α and IL-1 antagonists on periodonti-
tis showed a significant reduction of inflammation and bone resorption when administered 
either systemically or locally in the gingiva. The administration of antiTNF-α or TNF-α/Fc 
fusion protein had demonstrated significant reduction of the clinical and radiographic sig-
nals in rheumatoid arthritis and periodontal diseases [59]. IL-11 has antiinflammatory effects 
by induction of inhibition of TNF-α and other proinflammatory cytokines, thus the use of 
recombinant human IL-11 in the animal models showed significant reduction in the rate of 
clinical attachment and radiographic bone loss [60]. Similarly, the use of RANKL inhibitors 
in periodontitis, although limited in animal models [61] or in vitro assays [62], demonstrates 
a protective effect on bone resorption. The inhibition of PGE2 formation by nonsteroidal 
antiinflammatory drugs decreases osteoclasts formation and alveolar bone loss in humans 
and in animal experiments [63]. The United State Food Drug Administration approved the 
host modulator drug denominated subantimicrobial dose doxycycline (SDD), which inhibits 
matrix metalloproteinases and results in reduced progression of disease [64].
4. Genetic variants and the periodontitis risk
The development of periodontitis relies on multiple factors, and it is estimated that 50% of 
the expression of periodontitis could be attributed to genetic factors. The multifactorial etiol-
ogy of the periodontitis and the development of sequencing technology enabled us to discuss 
whether the variations of host's immunity affect the occurrence and development of the dis-
ease. Several immune response genes have been related to the protection or predisposition to 
CP, such as those responsible for bacterial antigens presentation to lymphocytes, as well as 
soluble mediators or membrane receptors that initiate or amplify the inflammatory process 
and bone loss.
4.1. Human leukocyte antigen (HLA)
HLA comprises of high polymorphic cell-surface molecules that have a key role in antigen 
presentation and activation of T cells. Because of the capability to bind periodontopatho-
gens peptides, HLA represents an important factor of risk or resistance to CP development. 
A metaanalysis focusing on Caucasian case-control studies demonstrated no associations 
between HLA and CP, although for aggressive periodontitis, HLA-A*09 and B*15 appeared 
to represent susceptibility factors, and HLA-A*02 and B*05 were potential protective factors 
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[65]. However, other studies provide evidence that class I and II HLA polymorphisms are 
associated with chronic periodontitis [66].
4.2. Pattern recognition receptors (PRRs)
PRRs play an important role in the recognition of periodontopathogens and genetic variations 
within the genes encoding them. They may have an important influence on immune response 
and in the pathogenesis of periodontal diseases [67].
TLR polymorphism may alter host susceptibility to periodontitis. The main studied polymor-
phism was related to TLR4 gene because TLR-4 is responsible for LPS recognition. TLR4 was 
associated with susceptibility of the periodontitis, although conflicting results are related [68]. 
TLR2 and TLR9 (except some TLR9 haplotypes) were not associated to CP development [69].
The CD14 −159C>T and −260 C>T promoter polymorphisms are located upstream from the 
major transcriptional site, affecting the transcriptional activity and CD14 density. Individuals 
homozygous for the mutation have increased serum levels of soluble sCD14 and an increased 
density of CD14 in monocytes. Thus, patients without mutation lead to a reduced expression 
of the CD14 receptor and may be more susceptible to CP. No association of CD14 polymor-
phism and CP was found in a metaanalysis study [70].
Mannose-binding lectin (MBL) polymorphisms were also associated to the severity of CP. 
Therefore, it is possible to affirm that periodontitis susceptibility was partly controlled by 
PRR polymorphisms involved in the innate immunity [71].
4.3. Cytokines
4.3.1. IL1
The IL1 genotypes appear to be the most studied genetic polymorphisms in CP. Associations 
between IL1 family polymorphisms and CP were initially assessed by Kornman et al. [72]. 
The authors observed that the simultaneous occurrence of IL1A −889 and IL1B +3953 poly-
morphisms was associated with severe periodontitis in nonsmokers. To date, the following 
IL1 genetic polymorphisms have been studied in association with CP: IL1A −889 (in linkage 
disequilibrium, LD, with +4845), IL1B −511 (in LD with −31), IL1B +3954 (also mentioned as 
+3953), and IL1RN VNTR (in LD with +2018). Different from others IL1 SNPs, IL1RN VNTR 
variant-alleles seem to decrease gene transcription or the protein production levels. Taken 
altogether, the IL1 gene cluster polymorphisms cannot be considered as risk factors for CP 
in the worldwide population. However, in Caucasians, an association between CP and IL1A 
−889 and IL1B +3953 mutate-allele may be genetic risk factors. The IL1 promoter SNPs and 
periodontitis might reflect subpopulation effects and have to be interpreted with care [72–74].
4.3.2. TNF
Several case-control studies in both Caucasians and nonCaucasians have investigated genetic 
polymorphisms in the TNF gene as putative risk factors for periodontitis. SNPs in the gene 
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encoding TNF are mainly studied in the promoter region at positions 1031, 863, 857, 376, 308, 
and 238 and also in the first intron at position +489. TNF −308 G/A and A/A genotypes were 
associated with increased CP risk in Asians, Caucasians, and nonsmoking Asians [75].
4.3.3. IL6
The IL6 −174G>C was found to influence IL-6 expression and production, and the individuals 
with carrier mutation present low IL6 gene transcriptional activity and low plasma levels of 
IL-6. Thus, the polymorphism may hamper individual’s defense against periodontal patho-
gens. Many studies had been found that IL6 −174 polymorphism may be associated with CP 
susceptibility and A. actinomycetemcomitans infection. However, a metaanalysis that included 
this polymorphism did not show any association for this polymorphism with CP [76, 77].
4.3.4. IL17
Two IL17 polymorphisms had been found associated to diseases: IL17A G197A (rs2275913) 
and IL17F T7488C (His161Arg, rs763780). The IL17A 197A allele correlates to more efficient 
IL-17 secretion and higher affinity for the nuclear factor activated T cells (NAFT), which is a 
critical regulator of the IL17 promoter gene. IL-17F activity is similar to IL-17A, but weaker, 
and the variant form of IL-17 protein suppresses the expression and the activity of wild type. 
IL17A AA genotype and A allele were associated with worse clinical and inflammatory peri-
odontal parameters. IL17F polymorphisms were not associated to CP [78].
4.3.5. IL10
Several promoter polymorphisms have been described in the IL10 gene: −1087 (−1082), −819 
(−824), −627, −592 (−597), and −590. There is strong linkage disequilibrium between IL10 
1082G>A, 819C>T, and 592C>A, and they form two common haplotypes on the basis of IL10 
−592 polymorphism. The allele A of the −592 has been associated with decreased synthesis of 
IL-10 in vitro and in vivo, and when present could modify the synthesis of IL-10 in response to 
inflammation. IL-10 has a protective role toward periodontal tissue destruction; therefore, the 
IL10 −592 polymorphism may be less protected against bacterial challenge and contribute to a 
relative increase in the risk for CP [79].
5. Conclusion
Chronic periodontitis is an inflammatory disease of the teeth-supporting tissues. The imbal-
ance between periodontopathogens and host factors is responsible for the transition of gin-
givitis into periodontitis and is estimated that 50% of the expression of periodontitis could 
be attributed to genetic factors. The genetic polymorphisms may in some situations cause a 
change in the protein or its expression possibly resulting in alterations in innate and adap-
tive immunity and may thus be deterministic in disease outcome. Thus, development and 
regulation of the immune response influence disease progression or resolution, and each 
person may have an individual response to the bacterial challenge. Most  individuals are 
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resistant to the disease and will not develop CP. The disease progression depends on the 
increased production of proinflammatory cytokines (IL-1α, IL-1β, IL-6, IL-8, and TNFα), 
metalloproteinases, and prostaglandins or decreased production of antiinflammatory cyto-
kines (IL-10, TGFβ) and inhibitors of metalloproteinases. The knowledge of the immuno-
pathogenesis mechanisms in the chronic periodontitis could contribute to new therapeutic 
approaches.
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